Skip to main content
. 2022 Mar 18;17(3):e0265551. doi: 10.1371/journal.pone.0265551

Fig 4. Pooled results of single-arm data for each therapeutic strategy.

Fig 4

(A) 5-year overall survival; (B) 5-year failure-free survival; (C) 5-year distant metastasis-free survival; (D) 5-year locoregional recurrence-free survival. A dotted line indicated the survival rate analyzed from all the data included in that figure.